share_log

Danone: Information on the Total Number of Voting Rights and Shares

Danone: Information on the Total Number of Voting Rights and Shares

達能:有關投票權和股份總數的信息
GlobeNewswire ·  2023/08/21 12:22

DANONE

達能

French Société anonyme with a capital of €169,443,282,00.
Registered Office: 17, boulevard Haussmann, 75009 Paris.
Registered with the Paris Commerce and Company Registry under number 552 032 534

法語́té匿名者協會擁有歐元的資本169,443,282,00
註冊處:巴黎奧斯曼大道17號,郵編:75009。
在巴黎商業和公司註冊處登記,號碼為552032534

Information on the total number of voting rights and shares

關於投票權和股份總數的資訊

in compliance with Article L. 233-8 II of the French Commercial Code and with Article 223-16 of the General Regulation of the Financial Markets Authority (AMF- Autorité des Marchés Financiers)

遵守《法國商法典》第L.233-8條第二款和《金融市場管理局一般規則》第223-16條(AUTORITÉdes Marchés Financers)

Date Total number of shares Total number of voting rights

31/07/2023

677,773,128

Total number of theoretical voting rights(1) : 700,633,817
Total number of exercisable voting rights(2) : 664,722,886
日期 股份總數 投票權總數

31/07/2023

677,773,128

理論投票權總數(1):700,633,817
可行使投票權的總數(2):664,722,886

(1) The total number of theoretical voting rights (or "gross" voting rights) is used as the basis for calculating the crossing of shareholding thresholds. In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended.

(一)以理論投票權(或“總”投票權)總數作為計算持股門檻跨越的依據。根據《AMF通則》第223-11條,這一數位是以所有附投票權的股份為基礎計算的,包括投票權已被暫停的股票

(2) The total number of exercisable voting rights (or "net" voting rights) is calculated without taking into account the shares with suspended voting rights. It is published to ensure that the public is properly informed in accordance with the recommendation made by the AMF on July 17, 2007.

(2)計算可行使表決權(或“淨”表決權)的總數時,不考慮暫停表決權的股份。公佈這份報告是為了確保公眾能按照基金在2007年7月17日提出的建議獲得適當的資訊。

Attachment

依附

  • Voting Rights and Share 310723
  • 投票權和股份310723

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論